Scaling up synergies between the Global Fund and innovators to break down barriers to health innovation for the most vulnerable

8 October 2019
Lyon, France

Ahead of the Global Fund’s Sixth Replenishment Conference, this event will bring together influential speakers and participants to discuss how synergistic investments in the Global Fund and in research and development can translate into accelerated delivery of innovative health tools which are affordable and accessible to the most vulnerable populations, thus saving many more lives and increasing the impact of Global Fund’s resources.

The event will also build on the recommendations made at a consultation in July 2019 with representatives from the Global Fund, the World Health Organization, product development partnerships and other innovators to identify and manage bottlenecks to scaling up access and uptake of health technologies to end HIV/AIDS, tuberculosis and malaria.

 

Speakers

Confirmed speakers include:

  • Aurélien Beaucamp, President, AIDES
  • Michèle Boccoz, Director-General Envoy for Multilateral Affairs, World Health Organization – WHO
  • Catharina Boehme, CEO, Foundation for Innovative New Diagnostics – FIND
  • Sherwin Charles, CEO, Nandos and Co-Founder of Goodbye Malaria
  • Tom McLean, Market Access Director, Innovative Vector Control Consortium
  • Bernard Pécoul, Executive Director, DNDi
  • David Reddy, CEO, Medicines for Malaria Venture – MMV
  • Zeda Rosenberg, CEO, International Partnership for Microbicides – IPM
  • Sanne Wendes, Unitaid Chief of Staff
  • Marijke Wijnroks, Chief of Staff, The Global Fund

Other high-level speakers are expected from the private sector, non-governmental organizations, research institutions and governments.

 

Practical information

Time: 16.00-17.30
Venue: room A at the H7 Centre

This meeting is by invitation only. If you are interested in attending, please email: innovate4gfimpact@mmv.org

Event website